Bristol-Myers Squibb Co. (NYSE:BMY)

CAPS Rating: 4 out of 5

Bristol-Myers Squibb discovers, develops, licenses, makes, and sells pharmaceuticals, with particular success in cardiovascular treatments.

Recs

0
Player Avatar 20100626 (< 20) Submitted: 8/6/2011 5:01:47 AM : Outperform Start Price: $25.90 BMY Score: +14.77

By Reader Request: Here's What to Buy If You're Opportunistic … but Still Scared - TMF staff

Report this Post Reply

Featured Broker Partners


Advertisement